Article
Protective Role of The SIGLEC14 Null Allele Against Type 2 Diabetes Mellitus: Evidence From an Egyptian Case-Control Study.
Molecular biology reports - 20 Jul 2026
Gabr Yasmine E, Arafa Lamiaa F, Morsi Heba K, Hammad Maha O
Abstract excerpt
BACKGROUND: Chronic inflammation plays a central role in the pathogenesis of type 2 diabetes mellitus (T2DM), with emerging evidence highlighting the regulatory role of sialic acid-binding immunoglobulin-like lectins (SIGLECs). The SIGLEC-14 null polymorphism, resulting in reduced pro-inflammatory signalling, may influence susceptibility to T2DM. This study aimed to investigate the association between the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
